SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-19-016692
Filing Date
2019-03-28
Accepted
2019-03-28 17:12:59
Documents
2
Period of Report
2019-05-09
Effectiveness Date
2019-03-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv517415_def14a.htm DEF 14A 415609
2 GRAPHIC image_001.jpg GRAPHIC 3967
  Complete submission text file 0001144204-19-016692.txt   422547
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37939 | Film No.: 19712891
SIC: 2834 Pharmaceutical Preparations